Overview A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours Status: Completed Trial end date: 2016-06-01 Target enrollment: Participant gender: Summary The purpose of the study is to evaluate the safety and biodistribution of [I-124]-CPD-1028 Injection in cancer patients with solid tumours. Phase: Phase 1 Details Lead Sponsor: Centre for Probe Development and Commercialization